Vision

We bring clinicians, industry researchers, and product developers together with scientists and engineers of multiple disciplines to tackle the challenge of highly controlled, well-characterized, efficient, reproducible, and high-quality therapeutic cell manufacturing.

Mission

The Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M) provides end-to-end R&D solutions for the whole spectrum of cell manufacturing needs. From Critical Quality Attributes (CQAs) identification to new Process Analytical Technologies (PATs) and process development, let MC3M be your partner.

Background

The Georgia Research Alliance (www.gra.org) and Georgia Tech lead the nationwide consortium (NIST/AmTech Cell Manufacturing Consortium) on cell characterization and manufacturing and developed the national roadmap for the United States to become a world leader in this space. Georgia Tech and the GRA conducted several national workshops to identify challenges faced by the cell manufacturing industry and academic/clinical GMP facilities. This roadmap forms the basis of research and development activities of the Marcus Center. The activities of the Center will be focused on collaborations across the United States with industry partners and clinicians and academic GMP facilities working on cell therapies.  When appropriate, international partners will be included. Many of these partnerships are already established through the Cell Manufacturing Consortium.